title: Treatment of hyperthyroidism in community hospital.
abstract: The preferred treatment of hyperthyroidism remains controversial. Most of this data is derived from large, university-based medical centers. We report here our experience with treatment of hyperthyroidism in a community setting. This involves 144 patients with hyperthyroidism who were seen over a 10 year period at Michigan State University Clinical Center and were treated in the community hospitals and private physicians' offices, and by community surgeons. Follow-up data were available on 119 of these patients; 105 of them were hyperthyroid because of Graves' disease and multinodular goiter. Patients were encouraged to make their own decisions regarding choice of therapy, as independently as possible. Sixty-five percent of these patients were treated by 131I, 18% by antithyroid drugs, and 17% by surgery. The mean follow-up period was 2.5 years (range 2 months to 19 years). Hyperthyroidism was controlled in 84% of the patients treated by 131I and 83% of the patients treated by surgery. Forty percent of the patients treated by 131I and 33% treated by surgery became hypothyroid. Fifty percent of the patients achieved remission when treated by antithyroid drugs alone. Our results indicate that when patients are encouraged to make their own decisions regarding the treatment of hyperthyroidism, their choices are similar to those of the thyroidologists. Secondly, the results obtained with different modalities of treatment for hyperthyroidism in a community setting are similar to those obtained in university medical centers.
authors.forename: V V
authors.initials: VV
authors.lastname: Gossain
authors.forename: R C
authors.initials: RC
authors.lastname: Heath
authors.forename: D R
authors.initials: DR
authors.lastname: Rovner
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D013956:Antithyroid Agents / Q000627:therapeutic use; D002648:Child; D002985:Clinical Protocols; D005260:Female; D005500:Follow-Up Studies; D006764:Hospitals, Community; D006801:Humans; D006980:Hyperthyroidism / Q000628:therapy*; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008824:Michigan; D008875:Middle Aged
chemical_list: D013956:Antithyroid Agents; D007457:Iodine Radioisotopes